Effect of steroids on the frequency of regulatory T Cells and expression of FOXP3 in a patient with systemic lupus erythematosus: A two-year follow-up [1]

Lupus

Volumn 16, Issue 5, 2007, Pages 374-377

  Cepika, Al M ^b   Marinic, I ^b   Morovic Vergles, J ^b   Soldo Juresa, D ^b   Gagro, Alenka ^a  

^a INSTITUTE OF IMMUNOLOGY   (Croatia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; MEDRONATE TECHNETIUM TC 99M; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RHEUMATOID FACTOR; STEROID; TRANSCRIPTION FACTOR FOXP3;

ADULT; ANEMIA; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD SAMPLING; BONE SCINTISCANNING; CASE REPORT; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEALTH CENTER; HOSPITALIZATION; HUMAN; KNEE ARTHRITIS; LABORATORY TEST; LETTER; MORNING STIFFNESS; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

FOLLOW-UP STUDIES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; STEROIDS; T-LYMPHOCYTES, REGULATORY; TIME FACTORS;

EID: 34447529156     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307077990     Document Type: Letter

References (15)

1. Sakaguchi S, Fukuma K, Kuribayashi K, Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T-cell subset. I. Evidence for the active participation of T cells in natural self-tolerance: deficit of a T-cell subset as a possible cause of autoimmune disease. J Exp Med 1985; 161: 72-87.
2. Ehrenstein MR, Evans JG, Singh A, Moore S et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 2004; 200: 277-285.
3. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199: 971-979.
4. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TI. Defective suppressor function in CD4+CD25+ T-cells from patients with type 1 diabetes. Diabetes 2005; 54: 92-99.
5. Crispin JC, Martínez A, Alcocer-Valera J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun 2003; 21: 273-276.
6. + T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 2004; 59: 198-202.
7. Mellor-Pita S, Citores MJ, Castejon R et al. Decrease of regulatory T cells in patients with systemic lupus erythematosus. Ann Rheum Dis 2006; 65: 553-554.
8. high T cell population in SLE patients treated with glucocorticoids. Ann Rheum Dis 2006; 65: 1512-1517.
9. Fields ML, Hondowicz BD, Metzgar MH et al. CD4+CD25+ regulatory T cells inhibit the maturation but not the initiation of an autoantibody response. J Immunol 2005; 175: 4255-4264.
10. Yagi H, Nomura T, Nakamura K et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 2004; 16: 1643-1656.
11. Ziegler FS. FOXP3: Of mice and men. Annu Rev Immunol 2006; 24: 7.1-7.18.
12. Karagiannidis C, Akdis M, Holopainen P et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004; 114: 1425-1433.
13. Gagro A, Tominac M, Krsulovic-Hresic V et al. Increased Toll-like receptor 4 expression in infants with respiratory syncytial virus bronchiolitis. Clin Exp Immunol 2004; 135: 267-272.
14. Lee JH, Wang LC, Lin YT, Yang YH, Lin DT, Chiang BL. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 2006; 117: 280-286.
15. Chen X, Murakami T, Oppenheim JJ, Howard OM. Differential response of murine CD4+CD25+ and CD4 + CD25- T cells to dexamethasone-induced cell death. Eur J Immunol 2004; 34: 859-869.